Not Signed In - Lupin Announces Approval Of Meloxicam Tablets
Fri, 21 Jul 2006 06:00 AM EST
... Lupin Pharmaceuticals, Inc.announced today that the U.S. Food and Drug Administration (FDA) hasgranted final approval for its Abbreviated New Drug Application (ANDA) forMeloxicam Tablets, 7.5 mg and 15 mg. The Company intends to initiateshipments immediately. Lupin's Meloxicam Tablets are the AB-rated generic equivalent ofBoehringer Ingelheim's MOBIC(R) Tablets. [click link for full article] ...
Related Topics
- Meloxicam
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Meloxicam Suspension
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Haloperidol Tablets
- Neostigmine Tablets
- Thiabendazole Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
- Fenofibrate Tablets
- Chlorpheniramine and Carbetapentane
email this page
print this page
bookmark this page
feedback on this page
